Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen

Summary

This is a Phase 2 randomized study to evaluate the safety and efficacy of IV Ampion in improving the clinical course and outcomes of adult COVID-19 patients requiring supplemental oxygen.

Timeline

Start

2021-07-05

Primary completion

2022-02-07

Completion

2022-04-04

Outcome

Outcome not reported

Stopped: “The AP-017 study was prematurely terminated by the sponsor after an interim analysis.”

Drugs

Indications